🧠AI AnalysisAbCellera Biologics Highlights Pipeline Progress and Phase II Data at Healthcare Conference
AbCellera Biologics CEO Carl Hansen discussed the company's proprietary antibody platform and the promising Phase II data for ABCL635 at the Stifel 2026 Healthcare Confer…